Changes in BDC counts after G-CSF or CY/G-CSF treatment.

CD123^hiBDC and CD11c⁺BDC counts (× 10⁶/L) were analyzed in steady state (SS; prior to commencement of the PBSC mobilization protocol), 1 day after commencement of the PBSC mobilization protocol (day 1), on the day of apheresis (DA), and at different time points thereafter. (A) Paired CD123^hiBDC and CD11c⁺BDC counts are shown in healthy donors, MM, and NHL patients. (B) Kinetic data from 3 representative subjects in each group is shown. The symbols identify the patients shown in (A). Low-dose G-CSF (10 μg/kg/d subcutaneously) is indicated by open symbols, high-dose G-CSF (30 μg/kg/d subcutaneously) by filled symbols.